News
Investing.com -- Celcuity Inc. (NASDAQ: CELC) stock rose 5.2% after the clinical-stage biotechnology company announced it will hold a conference call on Monday, July 28, 2025, to reveal topline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback